Actionnariat et activité des initiés pour Spero Therapeutics, Inc. (SPRO): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.11 |
| Capitalisation | $64M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-03 | Zack Debra | A-Award | 324,675 | $500K |
| 2026-08-03 | Zack Debra | A-Award | 162,311 | |
| 2026-08-03 | Zack Debra | |||
| 2026-06-23 | Deshpande Milind | A-Award | 10,000 | |
| 2026-06-23 | Deshpande Milind | A-Award | 20,000 | $43K |
| 2026-06-23 | Tregoning Kathleen | A-Award | 10,000 | |
| 2026-06-23 | Tregoning Kathleen | A-Award | 20,000 | $43K |
| 2026-06-23 | Smith Cynthia | A-Award | 10,000 | |
| 2026-06-23 | Smith Cynthia | A-Award | 20,000 | $43K |
| 2026-06-23 | VINK PATRICK V.J.J. | A-Award | 10,000 |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $10.3M | $87.3M | $34.1M | $29.7M | $85.2M | $112.6M | $109.1M | $76.3M | $52.9M | $40.3M |
| Placements à Court Terme | 0 | 0 | $81.4M | $52.3M | $41.7M | $33.8M | 0 | 0 | 0 | 0 |
| Créances | $304000 | $2.9M | $1.3M | $10.2M | 0 | $2.6M | $1.1M | $50.7M | $52.5M | $25.4M |
| Stocks | 0 | -$4.8M | -$8.8M | 0 | 0 | 0 | -$4.5M | 0 | 0 | 0 |
| Actifs Courants | $11.9M | $87.3M | $115.4M | $95.4M | $139.1M | $157.9M | $109.1M | $131.2M | $107.3M | $67.3M |
| Immobilisations Corporelles | $1.5M | $1.2M | $2.9M | $7.1M | $8.8M | $7.6M | $5.5M | $4.2M | $3.1M | $1.5M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $13.8M | $93.5M | $129.0M | $106.1M | $153.5M | $171.1M | $124.8M | $182.4M | $110.5M | $68.9M |
| Dettes Fournisseurs | $1.1M | $3.5M | $3.6M | $4.1M | $1.2M | $1.1M | $617000 | $1.4M | $7.3M | $693000 |
| Dette à Court Terme | 0 | 0 | 0 | $928000 | 0 | 0 | $1.7M | $1.7M | $1.7M | $2.0M |
| Passifs Courants | $6.9M | $8.2M | $12.3M | $26.7M | $14.3M | $18.7M | $21.6M | $37.2M | $49.1M | $8.9M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $7.4M | $8.5M | $13.2M | $31.5M | $21.4M | $82.8M | $48.9M | $75.5M | $64.4M | $9.9M |
| Réserves | -$45.4M | -$96.8M | -$138.5M | -$199.4M | -$277.7M | -$367.5M | -$413.9M | -$391.1M | -$459.6M | -$451.1M |
| Capitaux Propres | $10.2M | $85.0M | $115.9M | $74.6M | $132.0M | $88.3M | $75.9M | $106.9M | $46.1M | $59.0M |
| Dette Totale | 0 | 0 | 0 | $5.5M | $7.8M | $7.3M | $6.6M | $5.5M | $4.3M | $2.9M |
| Dette Nette | -$10.3M | -$87.3M | -$115.4M | -$76.5M | -$119.1M | -$139.1M | -$102.5M | -$70.8M | -$48.6M | -$37.4M |
| Fonds de Roulement | $5.0M | $79.1M | $103.1M | $68.8M | $124.8M | $139.2M | $87.5M | $94.1M | $58.2M | $58.4M |
Santé financière
| Dette / Capitaux propres | 0.05 |
| Ratio de liquidité | 6.12 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 0.63 |
Rentabilité
| Rentabilité des capitaux propres | 16.17% |
| Rentabilité du capital investi | 12.56% |
| Rentabilité des actifs | 13.99% |
| Marge brute | 100.00% |
| Marge opérationnelle | 14.02% |
| Marge nette | 17.18% |
Entreprises liées: ABOS · ACTU · CGTX · CRBP · HURA · INO · IRD
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de SPRO: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions